-Merck's Phase Ii/Iii Clinical Trial of Staphylococcus Aureus Vaccine V710 Suspends Enrolment

Summary


M2 EQUITYBITES-April 11, 2011-Merck's Phase II/III clinical trial of Staphylococcus aureus Vaccine V710 suspends enrolment

(C)1994-2011 M2 COMMUNICATIONS http://www.m2.com

See the full content of this document

Extract


-Merck's Phase Ii/Iii Clinical Trial of Staphylococcus Aureus Vaccine V710 Suspends Enrolment

Healthcare company Merck (NYSE:MRK) (MSD ou...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United Kingdom

Explore vLex

For Professionals

For Partners

Company